[Hematologic improvement with deferasirox following tandem antithymocyte globulin treatment in a transfusion-dependent patient with severe aplastic anemia].

Jomen, Wataru; Kuroda, Hiroyuki; Yamada, Michiko; Matsuno, Teppei; Sato, Masanori; Abe, Tomoyuki; Sakurai, Tamaki; Fujii, Shigeyuki; Maeda, Masahiro; Fujita, Miri; Nagashima, Kazuo; Iyama, Satoshi; Miyanishi, Koji; Kobune, Masayoshi; Kato, Junji

Jomen, Wataru; Kuroda, Hiroyuki; Yamada, Michiko; Matsuno, Teppei; Sato, Masanori; Abe, Tomoyuki; Sakurai, Tamaki; Fujii, Shigeyuki; Maeda, Masahiro; Fujita, Miri; Nagashima, Kazuo; Iyama, Satoshi; Miyanishi, Koji; Kobune, Masayoshi; Kato, Junji.

Affiliation

Jomen W; Department of Gastroenterology and Hematology/Clinical Oncology, Internal Medicine, Steel Memorial Muroran Hospital.

Rinsho Ketsueki ; 54(11): 2047-52, 2013 Nov.

Article in Ja | MEDLINE | ID: mdl-24305537

Subject(s)

Anemia, Aplastic/therapy; Antilymphocyte Serum/therapeutic use; Benzoates/therapeutic use; Blood Transfusion; Iron Chelating Agents/therapeutic use; Triazoles/therapeutic use; Anemia, Aplastic/etiology; Blood Transfusion/methods; Cyclosporine/therapeutic use; Deferasirox; Humans; Male; Middle Aged; Transfusion Reaction; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Triazoles / Benzoates / Blood Transfusion / Iron Chelating Agents / Anemia, Aplastic / Antilymphocyte Serum Type of study: Etiology_studies Language: Ja Journal: Rinsho Ketsueki Year: 2013 Type: Article

Search on Google

Add to My VHL

XML

PubMed Links